# Measuring treatment response and residual disease in leukemia with personalized, sensitive, and quantitative genomic methods

> **NIH NIH R00** · EMORY UNIVERSITY · 2024 · $53,685

## Abstract

Project Summary / Abstract
N/A

## Key facts

- **NIH application ID:** 11064589
- **Project number:** 3R00CA252616-04S1
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Andrea Moffitt
- **Activity code:** R00 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $53,685
- **Award type:** 3
- **Project period:** 2020-07-01 → 2026-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11064589

## Citation

> US National Institutes of Health, RePORTER application 11064589, Measuring treatment response and residual disease in leukemia with personalized, sensitive, and quantitative genomic methods (3R00CA252616-04S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11064589. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*